The HOMA-IR test is a simple blood test that estimates how resistant your body has become to insulin, the hormone responsible for moving sugar out of your bloodstream and into your cells. HOMA-IR stands for Homeostasis Model Assessment of Insulin Resistance, and it requires only two measurements from a single fasting blood draw: your blood sugar level and your insulin level. A score below about 1.0 is considered ideal, while values above 2.5 generally suggest meaningful insulin resistance.
How HOMA-IR Is Calculated
Your lab doesn’t measure HOMA-IR directly. Instead, it measures your fasting insulin and fasting glucose, then plugs both into a formula: fasting insulin (in µU/mL) multiplied by fasting glucose (in mmol/L), divided by 22.5. The result is a single number that reflects how hard your pancreas is working to keep your blood sugar in check.
The logic behind the formula is straightforward. In a healthy body, a small amount of insulin keeps blood sugar stable. If your cells start ignoring insulin’s signal (insulin resistance), your pancreas compensates by pumping out more. So a person with normal blood sugar but unusually high fasting insulin already has resistance, even though their glucose looks fine on a standard test. HOMA-IR captures that relationship.
What Your Score Means
There is no single universally agreed-upon cutoff, because optimal ranges vary by ethnicity, age, and body weight. That said, research across multiple populations offers useful benchmarks. In large population studies, reference ranges for healthy adults typically fall between roughly 0.6 and 4.3, with the midpoint around 1.0 to 1.5 in lean, metabolically healthy people. A cutoff of 2.5 is commonly used in research to flag insulin resistance, and a value of 1.77 has been proposed as an optimal threshold for non-diabetic individuals in some populations.
Higher scores mean your pancreas is producing more insulin than expected to maintain normal blood sugar. A HOMA-IR of 3.0 or 4.0 doesn’t mean you have diabetes, but it does suggest your body is working harder than it should. Over time, that extra burden on the pancreas can lead to rising blood sugar and eventually type 2 diabetes if the underlying resistance isn’t addressed.
How It Compares to the Gold Standard
The most precise way to measure insulin resistance is something called a hyperinsulinemic-euglycemic clamp, a labor-intensive procedure in which insulin and glucose are infused intravenously while researchers measure how much glucose your tissues absorb per minute. It’s the gold standard for research but completely impractical for routine clinical use because it takes hours, requires specialized equipment, and is expensive.
HOMA-IR correlates well with clamp results. In a study of patients with type 2 diabetes, the correlation between HOMA-IR and clamp-measured resistance was statistically significant both before and after treatment, and the relationship held steady over time. That makes HOMA-IR useful not only for an initial assessment but also for tracking whether lifestyle changes or treatment are actually improving your insulin sensitivity.
What You Need to Do Before the Test
HOMA-IR depends on fasting values, so you’ll need to skip food and all beverages except water the night before your blood draw. Most protocols call for an overnight fast of at least 8 hours, with typical fasting windows in studies averaging around 12 hours. Water is fine and encouraged. If you take medications that affect blood sugar or fat metabolism, such as oral corticosteroids, those can skew results and should be discussed with whoever ordered the test.
Conditions That Use HOMA-IR
Insulin resistance plays a role in several conditions beyond diabetes, and HOMA-IR is used to evaluate it across all of them. Polycystic ovary syndrome (PCOS) is one of the most common reasons a doctor might order this test in younger women, since insulin resistance is a frequent driver of the hormonal imbalances behind PCOS symptoms like irregular periods, acne, and difficulty conceiving. Metabolic syndrome, non-alcoholic fatty liver disease, and cardiovascular risk assessment are other contexts where HOMA-IR provides useful information.
For PCOS in particular, the choice of insulin resistance test matters. Research has shown that a significant percentage of women with PCOS can be classified as either insulin resistant or insulin sensitive depending on which method is used. HOMA-IR remains the most practical option, but your doctor may interpret the results alongside other clinical signs rather than relying on the number alone.
HOMA-B: The Other Half of the Picture
You may see HOMA-B reported alongside HOMA-IR. While HOMA-IR measures how resistant your cells are to insulin, HOMA-B estimates how well your pancreas is producing insulin in the first place. The two numbers tell complementary stories. Someone in the early stages of insulin resistance often has a high HOMA-IR (cells resisting) and a high HOMA-B (pancreas compensating). As the condition progresses and the pancreas starts to fatigue, HOMA-B drops while HOMA-IR stays elevated, signaling a slide toward diabetes.
Cohort research has found that rising HOMA-IR in people with normal blood sugar predicts a higher incidence of pre-diabetes over a six-year period. Rising HOMA-B, on the other hand, is associated with a higher risk of a specific pre-diabetes subtype where blood sugar spikes after meals but fasting levels remain normal. Together, the two values give a more complete snapshot of where your metabolism stands.
Limitations Worth Knowing
HOMA-IR is not perfect. Because it relies on fasting measurements, it primarily reflects how well your liver responds to insulin rather than how your muscles and fat tissue handle sugar after a meal. If your insulin resistance is mainly a post-meal problem, HOMA-IR may underestimate it. Tests that measure glucose and insulin during a glucose tolerance test (where you drink a sugary solution and give blood samples over two hours) capture that peripheral resistance more completely.
Body weight also affects accuracy. The correlation between HOMA-IR and clamp-measured resistance is stronger in people with a BMI above 25 than in leaner individuals. In people with a BMI below 25, the correlation weakens noticeably, meaning the test is less reliable at detecting mild resistance in thinner people.
Original HOMA vs. Updated HOMA2
The formula described above is the original 1985 model, sometimes called HOMA1. An updated version, HOMA2, was released in 1998 and accounts for several things the original ignores: differences in how the liver and muscles respond to insulin, changes in insulin secretion at very high blood sugar levels, and the presence of proinsulin (an insulin precursor that older assays sometimes count as insulin). HOMA2 uses a computer-based calculator rather than a simple equation and is calibrated so that a healthy young adult scores 100% for both insulin sensitivity and beta-cell function.
In practice, many labs still report HOMA1 because the formula is easy to calculate. If your results come from the University of Oxford’s HOMA2 calculator, the numbers won’t be directly comparable to HOMA1 values, so it’s worth confirming which version was used when comparing results over time or across different labs.